24.09.2021 16:10:23
|
Walgreens Says Pfizer COVID-19 Vaccine Booster Shots Now Available In U.S.
(RTTNews) - Walgreens said Friday that eligible individuals can now receive Pfizer COVID-19 booster vaccinations in stores nationwide, following the U.S. Food and Drug Administration Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention. Individuals can receive their flu and COVID-19 booster shots during the same appointment.
Eligible individuals can receive their booster shot at least six months after they completed their Pfizer COVID-19 primary vaccine series.
Individuals ages 65 and older; Long-term care facility residents ages 18 and older; Individuals ages 18 and older with underlying medical conditions. Individuals ages 18-64 who are at an increased risk for COVID-19 exposure and transmission because of occupational or institutional setting, such as healthcare and essential workers, are eligible to receive a booster dose at this time.
In addition, moderately to severely immunocompromised individuals who are already eligible to receive an additional dose of a Pfizer or Moderna COVID-19 vaccine can also receive a booster dose at least six months following their additional dose.
Walgreens said it is offering a $5 Walgreens Cash reward, when customer spend $20, after each vaccine received in store to individuals who have a registered myWalgreens account.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
04.02.25 |
Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks (Financial Times) | |
04.02.25 |
AKTIEN IM FOKUS: Ausblick bringt Merck & Co unter Druck - Pfizer auch im Minus (dpa-AFX) | |
04.02.25 |
ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar (dpa-AFX) | |
04.02.25 |
Pfizer vermeldet Umsatzsprung - Aktie dennoch schwächer (dpa-AFX) | |
04.02.25 |
S&P 500-Titel Pfizer-Aktie: So viel Verlust hätte ein Pfizer-Investment von vor 5 Jahren eingebracht (finanzen.at) | |
04.02.25 |
Ausblick: Pfizer stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
28.01.25 |
S&P 500-Wert Pfizer-Aktie: So viel Verlust hätte eine Investition in Pfizer von vor 3 Jahren bedeutet (finanzen.at) | |
21.01.25 |
S&P 500-Papier Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor einem Jahr verloren (finanzen.at) |
Analysen zu Pfizer Inc.mehr Analysen
05.02.25 | Pfizer Kaufen | DZ BANK | |
05.02.25 | Pfizer Buy | Goldman Sachs Group Inc. | |
05.02.25 | Pfizer Neutral | UBS AG | |
05.02.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
04.02.25 | Pfizer Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Pfizer Inc. | 24,83 | -0,14% |
|